Dec 19 (Reuters) - Biogen Inc, the U.S. drug maker
focused on neurological, autoimmune and rare diseases, said on
Monday it had appointed its chief commercial officer, Michel
Vounatsos, as chief executive officer, ending a five-month
search.
Read more
No comments:
Post a Comment